High Tech Pharm Co., Ltd. (KOSDAQ:106190)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,400
-300 (-1.91%)
At close: May 20, 2026
Market Cap168.11B +21.6%
Revenue (ttm)70.18B -9.5%
Net Income11.48B -16.3%
EPS1,072.37 -16.8%
Shares Out10.63M
PE Ratio14.74
Forward PEn/a
Dividend150.00 (0.96%)
Ex-Dividend DateDec 29, 2025
Volume28,972
Average Volume62,175
Open15,700
Previous Close15,700
Day's Range15,050 - 15,700
52-Week Range10,700 - 25,000
Betan/a
RSI34.30
Earnings DateMay 21, 2026

About High Tech Pharm

High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea. [Read more]

Founded 1998
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 106190
Full Company Profile

Financial Performance

In 2025, High Tech Pharm's revenue was 70.18 billion, a decrease of -9.46% compared to the previous year's 77.51 billion. Earnings were 11.48 billion, a decrease of -16.30%.

Financial Statements